All Articles in: Products
greenlight.guru Pitches New Medical Device Risk Management SoftwareSeptember 25, 2015
greenlight.guru announces the release of its new cloud-based Risk Management Software exclusively for medical device companies to help reduce risk and ensure compliance
New IFU Helps Physicians Select the Right Size EZ-IO® Vascular Access System Needle SetMarch 18, 2014
Newly FDA cleared Restated Indications for Use modify the weight range for Teleflex’s EZ-IO® 25 mm Needle Set for patients 3 kg or over.
First Implant of RTI’s map3™ Cellular Allogeneic Bone Graft in a Foot and Ankle ProcedureOctober 1, 2013
Surgical implant company RTI Surgical Inc. has seen a first implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant in a foot and ankle procedure. The case was complex, the immuno-compromised patient demanding a graft that would heal.
There’s an Orsiro for Every Case as Biotronik Extends Hybrid Drug Eluting Stent LineSeptember 3, 2013
Biotronik now boasts one of the longest drug-eluting stents on the market across all diameters with the market release of new 35 and 40 mm versions of Orsiro, the industry’s first hybrid Drug Eluting Stent (DES) featuring a bioabsorbable polymer.
“Kabir Is 14 And Has Worked In Pakistani Surgical Instrument Workshops Since He Was 8″November 1, 2012
Here’s a challenge. Watch the video and then say you don’t care where your medical devices come from as long as they’re cheap.
Here’s a Virtual Conference Rebroadcast on a proposed bill requiring the FDA to establish an Office of Mobile Health to help speed the development and approval of device apps.
Biomet To Distribute Bonesupport’s Proprietary Cerament™Bone Void FillerSeptember 10, 2012
Biomet is to be the exclusive distributor of Bonesupport’s proprietary Cerament™ bone void filler in an agreement which spans U.S. and Canada.
Navigator™ System Turns CV Data Into Information, Says StudyAugust 30, 2012
In a survey of triallists, 100% of respondents said that Navigator™ enhanced patient care. All said they would continue to use the cardiovascular monitoring and clinical decision-making system if made available.
Study Suggests Human Amniotic Membrane Product Dramatically Enhances Diabetic Foot Ulcer HealingAugust 10, 2012
MiMedx Group Inc., manufactures Epifix®, a wound treatment based on processed Human Amniotic Membrane. In a prospective randomised controlled study it appears the product significantly improves the healing rate of diabetic foot ulcers compared with standard of care only, to the extent that the trial was terminated early.
Surgical Innovations “Asks The Audience”July 19, 2012
UK device company Surgical Innovations welcomed some of the best minds in UK surgery to its annual event last week in what forms a key part of the company’s surgeon-led product and idea-development philosophy.
MIS Sacroiliac joint specialist SI-BONE, Inc. has issued a press release announcing that it has reached a significant milestone for its iFuse Implant System® with over 3,000 patients implanted. The device is used to minimally invasively fuse the sacroiliac joint.
Teleflex Incorporated has acquired Semprus BioSciences who’s core Semprus Sustain™ Technology for coating devices is designed to reduce the attachment of platelets and blood proteins at the device surface.
Humanitarian disasters usually bring out the best in people and the good folks who everyday tell us they work in the medical device business in order to help patients have another opportunity to do so by supporting an initiative by medical device translation company Crimson Life Sciences with medical equipment to help people suffering in Syria.
RhinoChill® Portable Brain Cooling Offers Earlier Neurological Protection For Heart Attack PatientsMay 2, 2012
The wonders of effective PR. Either that or RhinoChill® is taking off all on its own merits as this innovative portable brain cooling system receives coverage in all the right places. The concept of brain cooling for heart attack patients, taken right to the front line.
Study Says Non-invasive Magnetic Stimulation Is Effective In Treatment Of Major DepressionApril 19, 2012
Israeli company Brainsway put its money where its mouth is when it undertook a major clinical study into the effect of its therapy on unresponsive depression sufferers. The results suggest it paid off as significant improvements were noted in the treatment group.
Timed to coincide with AANS this week, Integra® LifeSciences Holdings Corporation has announced the United States full market release of the Integra® Vu aPOD™ Prime Intervertebral Body Fusion Device .
<< Previous Articles